Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study
Resource Type
Article
Authors
Orkin, Chloe ; Oka, Shinichi ; Philibert, Patrick ; Brinson, Cynthia ; Bassa, Ayesha ; Gusev, Denis ; Degen, Olaf ; García, Juan González ; Morell, Enrique Bernal ; Tan, Darrell H S ; D'Amico, Ronald ; Dorey, David ; Griffith, Sandy ; Thiagarajah, Shanker ; St Clair, Marty ; Van Solingen-Ristea, Rodica ; Crauwels, Herta ; Ford, Susan L ; Patel, Parul ; Chounta, Vasiliki ; Vanveggel, Simon ; Cutrell, Amy ; Van Eygen, Veerle ; Vandermeulen, Kati ; Margolis, David A ; Smith, Kimberly Y ; Spreen, William R
Source
In The Lancet HIV April 2021 8(4):e185-e196
Subject
Primary Research Articles
Language
ISSN
2352-3018